{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:14:35Z","timestamp":1774124075880,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.vaccine.2008.01.042","type":"journal-article","created":{"date-parts":[[2008,2,14]],"date-time":"2008-02-14T14:34:44Z","timestamp":1202999684000},"page":"1902-1911","source":"Crossref","is-referenced-by-count":56,"title":["Immunogenicity of HSP-70, KMP-11 and PFR-2 leishmanial antigens in the experimental model of canine visceral leishmaniasis"],"prefix":"10.1016","volume":"26","author":[{"given":"Eugenia","family":"Carrillo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00edn","family":"Crusat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Nieto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Chicharro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria del Carmen","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Basilio","family":"Valladares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ca\u00f1avate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Mar\u00eda","family":"Requena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel Carlos","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Alvar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11\u201312","key":"10.1016\/j.vaccine.2008.01.042_bib1","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int J Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.042_bib2","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1128\/JCM.39.2.560-563.2001","article-title":"Prevalence of Leishmania infantum infection in dogs living in an area of canine leishmaniasis endemicity using PCR on several tissues and serology","volume":"39","author":"Solano-Gallego","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.01.042_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4269\/ajtmh.2001.64.119","article-title":"Canine visceral leishmaniasis in Colombia: relationship between clinical and parasitologic status and infectivity for sand flies","volume":"64","author":"Travi","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2008.01.042_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1086\/344312","article-title":"Infectiousness in a cohort of Brazilian dogs: why culling fails to control visceral leishmaniasis in areas of high transmission","volume":"186","author":"Courtenay","year":"2002","journal-title":"J Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.01.042_bib5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0165-2427(99)00096-3","article-title":"The immune response and PBMC subsets in canine visceral leishmaniasis before, and after, chemotherapy","volume":"71","author":"Moreno","year":"1999","journal-title":"Vet Immunol Immunopathol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","article-title":"Chemotherapy of canine leishmaniosis","volume":"106","author":"Baneth","year":"2002","journal-title":"Vet Parasitol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2008.01.042_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.vetpar.2004.12.002","article-title":"Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate","volume":"128","author":"Pasa","year":"2005","journal-title":"Vet Parasitol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.042_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/vr.156.11.346","article-title":"Efficacy of the treatment of dogs with leishmaniosis with a combination of metronidazole and spiramycin","volume":"156","author":"Pennisi","year":"2005","journal-title":"Vet Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.042_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.1998.59.53","article-title":"Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil","volume":"59","author":"Ashford","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.vaccine.2008.01.042_bib12","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.vaccine.2006.10.036","article-title":"Immunogenicity of the P-8 amastigote antigen in the experimental model of canine visceral leishmaniasis","volume":"25","author":"Carrillo","year":"2007","journal-title":"Vaccine"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2008.01.042_bib13","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1051\/vetres:2005033","article-title":"Immunogenicity in dogs of three recombinant antigens (TSA LeIF and LmSTI1) potential vaccine candidates for canine visceral leishmaniasis","volume":"36","author":"Fujiwara","year":"2005","journal-title":"Vet Res"},{"issue":"9","key":"10.1016\/j.vaccine.2008.01.042_bib14","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1517\/14712598.4.9.1505","article-title":"Recent advances in vaccines for leishmaniasis","volume":"4","author":"Requena","year":"2004","journal-title":"Expert Opin Biol Ther"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2008.01.042_bib15","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/S0264-410X(00)00339-X","article-title":"A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto RN)","volume":"19","author":"da Silva","year":"2000","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.01.042_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"22","key":"10.1016\/j.vaccine.2008.01.042_bib17","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"29","key":"10.1016\/j.vaccine.2008.01.042_bib18","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1016\/j.vaccine.2007.05.010","article-title":"Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis","volume":"25","author":"Moreno","year":"2007","journal-title":"Vaccine"},{"issue":"45","key":"10.1016\/j.vaccine.2008.01.042_bib19","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2008.01.042_bib20","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"28","key":"10.1016\/j.vaccine.2008.01.042_bib21","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1016\/j.vaccine.2005.02.009","article-title":"Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum","volume":"23","author":"Rafati","year":"2005","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.01.042_bib22","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1016\/j.vaccine.2005.12.039","article-title":"Vaccination with a preparation based on recombinant cysteine peptidases and canine IL-12 does not protect dogs from infection with Leishmania infantum","volume":"24","author":"Poot","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1128\/CMR.12.1.19","article-title":"Role of heat shock proteins in protection from and pathogenesis of infectious diseases","volume":"12","author":"Zugel","year":"1999","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2008.01.042_bib24","doi-asserted-by":"crossref","first-page":"4105","DOI":"10.1128\/IAI.63.10.4105-4114.1995","article-title":"Immune responses of leishmaniasis patients to heat shock proteins of Leishmania species and humans","volume":"63","author":"Skeiky","year":"1995","journal-title":"Infect Immun"},{"issue":"17","key":"10.1016\/j.vaccine.2008.01.042_bib25","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0161-5890(99)00136-4","article-title":"Immunostimulatory properties of the Leishmania infantum heat shock proteins HSP70 and HSP83","volume":"36","author":"Rico","year":"1999","journal-title":"Mol Immunol"},{"issue":"49\u201350","key":"10.1016\/j.vaccine.2008.01.042_bib26","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1016\/j.vaccine.2006.07.006","article-title":"The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection","volume":"24","author":"Morell","year":"2006","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.042_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1006\/expr.1996.0101","article-title":"Trypanosoma cruzi: protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response","volume":"84","author":"Miller","year":"1996","journal-title":"Exp Parasitol"},{"issue":"8","key":"10.1016\/j.vaccine.2008.01.042_bib28","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.vaccine.2004.07.044","article-title":"Protective immunogenicity of the paraflagellar rod protein 2 of Leishmania mexicana","volume":"23","author":"Saravia","year":"2005","journal-title":"Vaccine"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2008.01.042_bib29","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3050307","article-title":"Isolation and structural characterization of the Leishmania donovani kinetoplastid membrane protein-11, a major immunoreactive membrane glycoprotein","volume":"305","author":"Jardim","year":"1995","journal-title":"Biochem J"},{"issue":"Pt 1","key":"10.1016\/j.vaccine.2008.01.042_bib30","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1042\/bj3050315","article-title":"Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11","volume":"305","author":"Jardim","year":"1995","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/expr.1996.4120","article-title":"Cloning of genes and expression and antigenicity analysis of the Leishmania infantum KMP-11 protein","volume":"85","author":"Berberich","year":"1997","journal-title":"Exp Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.042_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0165-2478(93)90179-6","article-title":"Production of interferon-gamma and interleukin-4 by human T cells recognizing Leishmania lipophosphoglycan-associated protein","volume":"38","author":"Kemp","year":"1993","journal-title":"Immunol Lett"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.042_bib33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1365-2249.1994.tb06044.x","article-title":"Dichotomy of the human T cell response to Leishmania antigens II. Absent or Th2-like response to gp63 and Th1-like response to lipophosphoglycan-associated protein in cells from cured visceral leishmaniasis patients","volume":"96","author":"Kurtzhals","year":"1994","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.01.042_bib34","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","volume":"174","author":"Basu","year":"2005","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2307\/3283159","article-title":"Canine leishmaniasis: pathological and ecological factors influencing transmission of infection","volume":"77","author":"Abranches","year":"1991","journal-title":"J Parasitol"},{"issue":"9","key":"10.1016\/j.vaccine.2008.01.042_bib36","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1471-4922(02)02347-4","article-title":"Canine leishmaniasis: epidemiological risk and the experimental model","volume":"18","author":"Moreno","year":"2002","journal-title":"Trends Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib37","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/IAI.66.1.347-352.1998","article-title":"Characterization of the immunostimulatory properties of Leishmania infantum HSP70 by fusion to the Escherichia coli maltose-binding protein in normal and nu\/nu BALB\/c mice","volume":"66","author":"Rico","year":"1998","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0952-7915(06)80029-4","article-title":"Heat-shock proteins: immunity and autoimmunity","volume":"4","author":"Young","year":"1992","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpara.2004.10.015","article-title":"Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs","volume":"35","author":"Strauss-Ayali","year":"2005","journal-title":"Int J Parasitol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.01.042_bib41","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2004.08.010","article-title":"Semi-quantitative analysis of cytokine expression in asymptomatic canine leishmaniasis","volume":"103","author":"Chamizo","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.042_bib42","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.vaccine.2005.11.011","article-title":"Prime-boost vaccination using cysteine proteinases type I and II of Leishmania infantum confers protective immunity in murine visceral leishmaniasis","volume":"24","author":"Rafati","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2008.01.042_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1017\/S0031182000065793","article-title":"During canine viscero-cutaneous leishmaniasis the anti-Hsp70 antibodies are specifically elicited by the parasite protein","volume":"112","author":"Quijada","year":"1996","journal-title":"Parasitology"},{"issue":"3","key":"10.1016\/j.vaccine.2008.01.042_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(98)00071-6","article-title":"Analysis of the antigenic properties of the L. infantum Hsp70: design of synthetic peptides for specific serodiagnosis of human leishmaniasis","volume":"63","author":"Quijada","year":"1998","journal-title":"Immunol Lett"},{"issue":"2","key":"10.1016\/j.vaccine.2008.01.042_bib46","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1432-1033.1990.tb15586.x","article-title":"Identification and characterisation of a Leishmania donovani antigen belonging to the 70-kDa heat-shock protein family","volume":"190","author":"MacFarlane","year":"1990","journal-title":"Eur J Biochem"},{"issue":"12","key":"10.1016\/j.vaccine.2008.01.042_bib47","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1128\/IAI.65.12.5368-5370.1997","article-title":"Association of Leishmania heat shock protein 83 antigen and immunoglobulin G4 antibody titers in Brazilian patients with diffuse cutaneous leishmaniasis","volume":"65","author":"Skeiky","year":"1997","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1379\/1466-1268(2002)007<0339:THSPHA>2.0.CO;2","article-title":"The heat shock proteins, Hsp70 and Hsp83, of Leishmania infantum are mitogens for mouse B cells","volume":"7","author":"Rico","year":"2002","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib49","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2307\/3279070","article-title":"Experimental Chagas\u2019 disease: protective activity in relation with subcellular fractions of the parasite","volume":"62","author":"Segura","year":"1976","journal-title":"J Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.01.042_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1550-7408.1977.tb01009.x","article-title":"Antigens of the subcellular fractions of Trypanosoma cruzi. II. Flagellar and membrane fraction","volume":"24","author":"Segura","year":"1977","journal-title":"J Protozool"},{"issue":"2\u20133","key":"10.1016\/j.vaccine.2008.01.042_bib51","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0167-4781(98)00176-6","article-title":"The expression of the Leishmania infantum KMP-11 protein is developmentally regulated and stage specific","volume":"1442","author":"Berberich","year":"1998","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.vaccine.2008.01.042_bib52","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0169-4758(00)01651-3","article-title":"Evolutionarily conserved proteins as prominent immunogens during Leishmania infections","volume":"16","author":"Requena","year":"2000","journal-title":"Parasitol Today"},{"key":"10.1016\/j.vaccine.2008.01.042_bib53","doi-asserted-by":"crossref","unstructured":"Kemp M, Kurtzhals JA, Kharazmi A, Theander TG. Interferon-gamma and interleukin-4 in human Leishmania donovani infections. Immunol Cell Biol 1993;71(Pt 6):583\u20137.","DOI":"10.1038\/icb.1993.64"},{"issue":"1","key":"10.1016\/j.vaccine.2008.01.042_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0166-6851(95)00022-S","article-title":"Kinetoplastid membrane protein-11 (KMP-11) is differentially expressed during the life cycle of African trypanosomes and is found in a wide variety of kinetoplastid parasites","volume":"71","author":"Stebeck","year":"1995","journal-title":"Mol Biochem Parasitol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08001011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08001011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T00:32:27Z","timestamp":1588379547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08001011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":54,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0264410X08001011"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.01.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}